The identification of risk factors for development of SBP (including ascitic fluid protein concentration 1.0 g/dL, variceal hemorrhage, and prior episode of SBP) has led to randomized controlled trials of prophylactic anti
The identification of risk factors for development ofSBP (including ascitic fluid protein concentration 1.0g/dL, variceal hemorrhage, and prior episode of SBP) hasled to randomized controlled trials of prophylactic anti